Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IAM1363 |
Trade Name | |
Synonyms | IAM-H1|ENT-H1 |
Drug Descriptions |
IAM1363 irreversibly inhibits wild-type and mutant ERBB2 (HER2), including exon 20 insertions, potentially leading to tumor growth inhibition (Cancer Res (2023) 83 (7_Supplement): 4034). |
DrugClasses | HER2 Inhibitor 42 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IAM1363 | IAM1363 | 0 | 1 |
IAM1363 + Trastuzumab | IAM1363 Trastuzumab | 0 | 1 |